Roundup of media coverage of MedImmune v. Genentech decision
After last week's Supreme Court decision in MedImmune v. Genentech holding a patent licensee in good standing need not breach the license agreement in order to bring a claim that the patent is invalid, not infringed, or unenforceable, the media has begun to offer its perspective on the case. Below is a sampling of the media coverage, which basically is in agreement that the decision makes it easier to challenge patents, with some arguing that the result is contrary to the purpose of entering into a license agreement in the first place.
- Wall Street Journal (subscription required)
- Los Angeles Times
- New York Times (subscription required)
- CNBC
- MSNBC
- U.S. News & World Report
- Minneapolis Star Tribune
- Law.com
- The Manufacturer (UK)
A sampling of blog coverage:
There are no comments for this entry.
[Add Comment]